Filing Details

Accession Number:
0001209191-19-054497
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-30 16:02:11
Reporting Period:
2019-10-28
Accepted Time:
2019-10-30 16:02:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1654151 Deciphera Pharmaceuticals Inc. DCPH Pharmaceutical Preparations (2834) 200299725
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1713712 Lee Daniel Flynn C/O Deciphera Pharmaceuticals, Inc.
500 Totten Pond Road
Waltham MA 02451
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-28 29,820 $1.89 54,320 No 4 M Direct
Common Stock Disposition 2019-10-28 29,820 $40.00 24,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-10-28 29,820 $0.00 29,820 $1.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
319,751 2025-12-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 66,779 Indirect By Daniel L. Flynn Irrevocable Trust
Common Stock 55,270 Indirect By Biochenomix, LLC
Footnotes
  1. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015.